Effects of oxysterols on the blood-brain barrier: Implications for Alzheimer's disease

被引:52
|
作者
Gosselet, Fabien
Saint-Pol, Julien
Fenart, Laurence
机构
[1] Univ Lille Nord France, Lille, France
[2] UArtois, LBHE, EA 2465, Lens, France
[3] IMPRT IFR114, Lille, France
关键词
Oxysterols; Blood-brain barrier; ABCA1; ABCB1; Alzheimer's disease; LXR; CAPILLARY ENDOTHELIAL-CELLS; AMYLOID-BETA-PEPTIDE; BODY CHOLESTEROL METABOLISM; TO-BASOLATERAL TRANSPORT; TRANSGENIC MOUSE MODEL; P-GLYCOPROTEIN; IN-VITRO; APOLIPOPROTEIN-E; A-BETA; NEURODEGENERATIVE DISEASES;
D O I
10.1016/j.bbrc.2013.11.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Altered brain cholesterol homeostasis plays a key role in neurodegenerative diseases such as Alzheimer's disease (AD). For a long time, the blood-brain barrier (BBB) was basically considered as a barrier isolating the brain from circulating cholesterol, however, several lines of evidence now suggest that the BBB strictly regulates the exchanges of sterol between the brain and the peripheral circulation. Oxysterols, synthesized by neurons or by peripheral cells, cross the BBB easily and modulate the expression of several enzymes, receptors and transporters which are involved not only in cholesterol metabolism but also in other brain functions. This review article deals with the way oxysterols impact BBB cells. These perspectives open new routes for designing certain therapeutical approaches that target the BBB so that the onset and/or progression of brain diseases such as AD may be modulated. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:687 / 691
页数:5
相关论文
共 50 条
  • [31] Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
    Simic, Goran
    Spanic, Ena
    Horvat, Lea Langer
    Hof, Patrick R.
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 99 - 145
  • [32] Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease
    Zhao, Ming
    Jiang, Xue-Fan
    Zhang, Hui-Qin
    Sun, Jia-Hui
    Pei, Hui
    Ma, Li-Na
    Cao, Yu
    Li, Hao
    AGEING RESEARCH REVIEWS, 2021, 72
  • [33] Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer's Disease
    Rocha, Sandra
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (37) : 6635 - 6646
  • [34] Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease
    Yamazaki, Yu
    Kanekiyo, Takahisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (09)
  • [35] Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells
    Fanaee-Danesh, Elham
    Gali, Chaitanya Chakravarthi
    Tadic, Jelena
    Zandl-Lang, Martina
    Kober, Alexandra Carmen
    Roca Agujetas, Vicente
    de Dios, Cristina
    Tam-Amersdorfer, Carmen
    Stracke, Anika
    Albrecher, Nicole Maria
    Manavalan, Anil Paul Chirackal
    Reiter, Marielies
    Sun, Yidan
    Colell, Anna
    Madeo, Frank
    Malle, Ernst
    Panzenboeck, Ute
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (09): : 2224 - 2245
  • [36] Blood-Brain Barrier ABC-transporter P-glycoprotein in Alzheimer's Disease: Still a Suspect?
    van Assema, Danielle M. E.
    van Berckel, Bart N. M.
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (38) : 5808 - 5816
  • [37] siRNA drug delivery across the blood-brain barrier in Alzheimer's disease
    Sajid, Muhammad Imran
    Sheikh, Fahad Sultan
    Anis, Faiza
    Nasim, Nourina
    Sumbria, Rachita K.
    Nauli, Surya M.
    Tiwari, Rakesh Kumar
    ADVANCED DRUG DELIVERY REVIEWS, 2023, 199
  • [38] Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease
    Liu, Lumei
    Wan, Wenbin
    Xia, Shijin
    Kalionis, Bill
    Li, Yaming
    NEUROCHEMISTRY INTERNATIONAL, 2014, 75 : 19 - 25
  • [39] The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?
    Pan, Yijun
    Khalil, Hanan
    Nicolazzo, Joseph A.
    CURRENT CLINICAL PHARMACOLOGY, 2015, 10 (03): : 222 - 241
  • [40] Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment
    Chaves, Juliana C. S.
    Dando, Samantha J.
    White, Anthony R.
    Oikari, Lotta E.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (02):